Sun Xiaoping, Xu Min, Liu Haiyan, Ming Kunxiu
Department of Emergency, Yidu Central Hospital of Weifang, Weifang Medical University, Weifang, Shandong 262500, P.R. China.
Department of Emergency Medicine, Weifang People's Hospital, Weifang, Shandong 261000, P.R. China.
Mol Med Rep. 2024 Jul;30(1). doi: 10.3892/mmr.2024.13237. Epub 2024 May 17.
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell migration and invasion assay data shown in Figs. 2C and 4C were strikingly similar to data that had already been published in different form in another article written by different authors at a different research institute [Yang S, Zhang Y, Zhao X, Wang J and Shang J: microRNA‑361 targets Wilms' tumor 1 to inhibit the growth, migration and invasion of non‑small‑cell lung cancer cells. Mol Med Rep 14: 5415‑5421, 2016]. Owing to the fact that the contentious data in the above article had already been published prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 16: 3557‑3564, 2017; DOI: 10.3892/mmr.2017.7000].
在本文发表后,一位关切的读者提请编辑注意,图2C和4C所示的某些Transwell迁移和侵袭试验数据与另一家不同研究机构的不同作者撰写的另一篇文章中已以不同形式发表的数据惊人地相似[Yang S, Zhang Y, Zhao X, Wang J和Shang J:微小RNA-361靶向肾母细胞瘤1以抑制非小细胞肺癌细胞的生长、迁移和侵袭。《分子医学报告》14: 5415-5421, 2016]。由于上述文章中有争议的数据在提交给本期刊之前就已经发表,编辑决定将本文从本刊撤回。已要求作者对这些问题作出解释,但编辑部未收到答复。编辑就由此造成的不便向读者致歉。[《分子医学报告》16: 3557-3564, 2017;DOI: 10.3892/mmr.2017.7000]